Riskpilot← Back to searchSign inGet full accessOLIGOMAKER ApS
APSActiveCVR 12783388Kong Georgs Vej 12BManufacture of basic pharmaceutical products · NACE 2110Est. 19892 employeeswww.oligomaker.com
Revenue 2025
DKK -145K
-105% vs 2024
EBITDA margin
907.0%
-175% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
DKK -1,4M
-206% vs 2024
| Revenue | DKK -145K | -105% |
| EBITDA | DKK -1,3M | -175% |
| Net profit | DKK -1,4M | -206% |
| Total assets | DKK 2,1M | -54% |
| Equity | DKK 1,9M | -17% |
| Employees | 2 | — |
Legal name
OLIGOMAKER ApS
CVR number
12783388
Legal form
Anpartsselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
1. januar 1989
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive virksomhed med handel, forskning og produktion og udføre andre i forbindelse hermed stående erhvervsmæssige opgaver.
Address
Kong Georgs Vej 12B
Phone
+4520193646
Email
karl@ross.dk
Website
www.oligomaker.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49 | 77 | 856 | 90 | 453 | 354 | 1.049 | 1.318 | 2.638 | 2.556 | 3.610 | 3.278 | 2.799 | -145 |
| Staff expenses | -0 | -0 | -0 | -0 | -43 | -347 | -371 | -490 | -188 | -31 | -21 | -817 | -1.051 | -1.166 |
| EBITDA | 49 | 77 | 856 | 90 | 410 | 6 | 678 | 828 | 2.451 | 2.525 | 3.589 | 2.461 | 1.748 | -1.311 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 49 | 77 | 856 | 90 | 410 | 6 | 678 | 828 | 2.451 | 2.525 | 3.589 | 2.461 | 1.748 | -1.311 |
| Net financials | -5 | 1 | 35 | 34 | -6 | -3 | -0 | -1 | 11 | -21 | -58 | -102 | -79 | -72 |
| Profit before tax | 44 | 79 | 891 | 124 | 404 | 4 | 678 | 827 | 2.462 | 2.504 | 3.530 | 2.359 | 1.669 | -1.383 |
| Tax | 11 | 20 | 219 | 29 | 89 | 1 | 149 | 182 | 545 | 552 | 781 | 522 | 369 | -0 |
| Net profit | 33 | 59 | 672 | 95 | 315 | 3 | 529 | 645 | 1.917 | 1.952 | 2.749 | 1.837 | 1.300 | -1.383 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 630 | 1.012 | 1.614 | 1.744 | 1.709 | 886 | 1.348 | 2.055 | 4.349 | 4.186 | 4.308 | 3.752 | 4.564 | 2.103 |
| Equity | 503 | 561 | 1.233 | 1.328 | 1.143 | 446 | 975 | 1.120 | 2.537 | 2.489 | 2.939 | 2.476 | 2.276 | 1.892 |
| Long-term debt | 0 | 20 | 219 | 29 | 89 | 1 | 149 | 182 | 558 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 127 | 431 | 162 | 386 | 476 | 439 | 224 | 753 | 1.254 | 1.697 | 1.370 | 1.276 | 2.288 | 210 |
| Total debt | 127 | 451 | 381 | 416 | 565 | 440 | 373 | 935 | 1.812 | 1.697 | 1.370 | 1.276 | 2.288 | 210 |
EBITDA margin
-131094300.0%
This company
15.8%
Market median
-829710859% vs market
20122025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20122025
Return on equity
-73.1%
This company
18.4%
Market median
-497% vs market
20122025
Net profit margin
-138337800.0%
This company
8.1%
Market median
-1707874174% vs market
20122025
Asset turnover
-0.07×
This company
1.12×
Market median
-106% vs market
20122025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PH Management | Management | 1989 | — | — |
SS Management | Management | 1989 | — | — |
KJ Management | Management | 2006 | — | — |
JR Management | Management | 1989 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1989 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
K.J. ROSS-PETERSEN ApS | Company | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
K.J. ROSS-PETERSEN ApS
OLIGOMAKER ApS Board members of OLIGOMAKER ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Høpfner | Management | 0 companies |
| Steen Schierbeck | Management | 0 companies |
| Karl Jakob Ross-Petersen | Management | 0 companies |
| Jakob Riemann Ross-Petersen | Management | 0 companies |
| Lone Ross Nylandsted | Board of Directors | 0 companies |